|
|
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer.
Jean-Louis Formento
,
Marie-Christine Etienne-Grimaldi
,
Mireille Francoual
,
Gilles Pagès
,
Cercina Onesto
et al.
Journal articles
hal-00435702v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
New advances in DPYD genotype and risk of severe toxicity under capecitabine
Marie-Christine Etienne-Grimaldi
,
Christophe Boyer
,
Christophe Béroud
,
Litaty Mbatchi
,
André van Kuilenburg
et al.
Journal articles
hal-01780001v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevention of 5-fluorouracil–induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing
Marie-Christine Etienne-Grimaldi
,
Chantal Barin Le Guellec
,
Jean-Christophe Boyer
,
Etienne Chatelut
,
Alexandre Evrard
et al.
Journal articles
hal-01892184v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02).
Juliette Thariat
,
René-Jean Bensadoun
,
Marie-Christine Etienne-Grimaldi
,
Dominique Grall
,
Frédérique Penault-Llorca
et al.
Journal articles
hal-00770510v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis
Juliette Thariat
,
Nicolas Azzopardi
,
Frederic Peyrade
,
Vincent Launay-Vacher
,
Jose Santini
et al.
Journal of Clinical Oncology, 2008, 26 (25), pp.4223-4225
Journal articles
hal-00616934v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Marie-Anne Loriot
,
Fadil Masskouri
,
Paolo Carni
,
Karine Le Malicot
,
Jean-François Seitz
et al.
Journal articles
hal-02530344v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Médicaments de haute technologie en oncologie : High-technology drugs in oncology
Marie-Christine Etienne-Grimaldi
,
P. Couvreur
,
Jean-Pierre Benoit
,
R. Fanciullino
,
J. Sergent
et al.
Journal articles
hal-03173117v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency
Maud Maillard
,
Manon Launay
,
Bernard Royer
,
Jérôme Guitton
,
Elodie Gautier-Veyret
et al.
Journal articles
hal-03923649v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture.
Juliette Thariat
,
Marie-Christine Etienne-Grimaldi
,
Dominique Grall
,
René-Jean Bensadoun
,
Anne Cayre
et al.
Journal articles
hal-00770516v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
Coralie Dorard
,
Aurélie de Thonel
,
Ada Collura
,
Laetitia Marisa
,
Magali Svrcek
et al.
Journal articles
hal-03030335v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency
Maud Maillard
,
Manon Launay
,
Bernard Royer
,
Jérome Guitton
,
Elodie Gautier-Veyret
et al.
Journal articles
hal-03789849v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A French prospective pilot study for identifying dihydropyrimidine dehydrogenase (DPD) deficiency in breast cancer patients (pts) receiving capecitabine (cap)
Marie-Christine Etienne-Grimaldi
,
Jean-Marc Ferrero
,
Fabienne Thomas
,
Christine Bobin-Dubigeon
,
Jean-Louis Merlin
et al.
2013 ASCO Annual Meeting, May 2013, Chicago, Il, United States. pp.CDROM
Conference papers
hal-00831930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer
Gilles Manceau
,
Laetitia Marisa
,
Valérie Boige
,
Alex Duval
,
Marie-Pierre Gaub
et al.
Journal articles
hal-01213515v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic Exposure
Antonin Schmitt
,
Laurence Gladieff
,
Céline Laffont
,
Alexandre Evrard
,
Jean-Christophe Boyer
et al.
Journal articles
hal-03388069v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx
Marie-Anne Loriot
,
Joseph Ciccolini
,
Fabienne Thomas
,
Chantal Barin-Le-Guellec
,
Bernard Royer
et al.
Journal articles
hal-01930855v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exhaustive single nucleotide polymorphism (SNP) analysis of DPYD exome in breast cancer patients (pts) receiving capecitabine
Marie-Christine Etienne-Grimaldi
,
Jean-Christophe Boyer
,
Laurence Llorca
,
Gilles Romieu
,
Thomas Bachelot
et al.
ASCO 2015 annual meeting, May 2015, Chicago, IL, United States. pp.abstr 2571
Conference papers
hal-01241771v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency
Marie-Christine Etienne-Grimaldi
,
Nicolas Pallet
,
Valérie Boige
,
Joseph Ciccolini
,
Laurent Chouchana
et al.
Journal articles
hal-03934173v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nuclear localization of a novel human syntaxin 1B isoform
Sandrine Pereira
,
Annick Massacrier
,
Patrice Roll
,
Alain Vérine
,
Marie-Christine Etienne-Grimaldi
et al.
Journal articles
istex
hal-00831154v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|